Pregabalin for the treatment of generalized anxiety disorder (GAD): Efficacy and safety in elderly patients

被引：0
|
作者：
Garcia, J. Bobes
Montgomery, S.
Baldinetti, F.
Leon, T.
Mandel, F.
Pauer, L.
Chatamra, K.
机构：
[1] Hosp Psiquiatrico Reg, Oviedo, Spain
[2] Imperial Coll Sch Med, London, England
[3] Pfizer Inc, Pfizer Global Pharmaceut, New York, NY USA
[4] Pfizer Global Res & Dev, Ann Arbor, MI USA
[5] Pfizer Global Res & Dev, Sandwich, Kent, England
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of milnacipran in the treatment of generalized anxiety disorder: an open study
    Tsukamoto, T
    Kondoh, R
    Ichikawa, K
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2004, 8 (04) : 255 - 258
  • [42] Pregabalin in generalized anxiety disorder: Long term efficacy and relapse prevention
    Smith, W
    Feltner, D
    Kavoussi, R
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S350 - S350
  • [43] Pregabalin's efficacy in achieving remission in outpatients with generalized anxiety disorder
    Wittehen, H. U.
    Baldinetti, F.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S466 - S467
  • [44] Drug treatment of generalized anxiety disorder (GAD) -: a consensus statement
    Bandelow, Borwin
    Boerner, Reinhard J.
    Kasper, Siegfried
    Linden, Michael
    Volz, Hans-Peter
    Wittchen, Hans-Ulrich
    Moeller, Hans-Juergen
    [J]. PSYCHOPHARMAKOTHERAPIE, 2007, 14 (04): : 136 - +
  • [45] Cost effectiveness of escitalopram in the treatment of Generalized Anxiety Disorder (GAD)
    Walker, JH
    Bereza, BG
    Hemels, M
    Le Melledo, JM
    Iskedjian, M
    Einarson, T
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A195 - A196
  • [46] Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
    Baldwin, David S.
    Schweizer, Edward
    Xu, Yikang
    Lyndon, Gavin
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (02) : 137 - 142
  • [47] Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder
    Kasper, Siegfried
    Iglesias-Garcia, Celso
    Schweizer, Edward
    Wilson, Jacquelyn
    DuBrava, Sarah
    Prieto, Rita
    Pitman, Verne W.
    Knapp, Lloyd
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (05): : 685 - 695
  • [48] Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
    Zou, Chuan
    Ding, Xiang
    Flaherty, Joseph H.
    Dong, Birong
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1661 - 1670
  • [49] Recent developments in the treatment of Panic Disorder (PD) and Generalized Anxiety Disorder (GAD)
    Kasper, Siegfried
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [50] Pregabalin treatment of generalised anxiety disorder (GAD); Three randomised, placebo controlled trials
    Pande, AC
    Crockatt, JG
    Janney, C
    Feltner, DE
    [J]. EUROPEAN PSYCHIATRY, 2000, 15 : 244S - 244S
12345